← BDX

BDXBCAL DIAGNOSTICS LIMITED

Announcement history available from 1 August 2025

Fromto
Date / TimeTitleTypeMSReport Codes
6 Aug 2026, 19:34Bioshares Conference Investor PresentationPresentations—03026
30 July 2026, 18:38Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19004, 19009
15 July 2026, 04:51Notification regarding unquoted securities - BDXOther—06021
15 July 2026, 04:44Notification regarding unquoted securities - BDXOther—06021
15 July 2026, 04:32Notification regarding unquoted securities - BDXOther—06021
15 July 2026, 04:20Notification regarding unquoted securities - BDXOther—06021
3 July 2026, 03:13Becoming a substantial holder for GSSOther——
2 July 2026, 20:04BCAL to Acquire Shares in Genetic SignaturesCompany UpdateMS11001
29 June 2026, 19:57BCAL Secures Funding for FY2027Periodic ReportsMS03014, 06009
18 June 2026, 19:52BCAL Develops New Blood Test for Breast Cancer RecurrenceCompany UpdateMS11001
28 May 2026, 18:25Validation Agreement Signed with Sonic USA, for Breastest V2Company Update—11001
19 May 2026, 20:09BCAL Launches Early Detection Cancer PlatformCompany UpdateMS11001
11 May 2026, 18:23BCAL Appoints Anne-Louise Arnett as Chief Executive OfficerOtherMS12017, 12019
22 Apr 2026, 18:50Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19003, 19008
31 Mar 2026, 20:11BCAL Submits MSAC Application for Avantect Pancreatic TestCompany Update—11001
26 Mar 2026, 20:19BCAL Accelerates Rollout of Avantect Early Detection TestsCompany UpdateMS11001
21 Mar 2026, 04:08Change of Director's Interest NoticeDirector Interests—02009
20 Mar 2026, 04:21Change of Director's Interest NoticeDirector Interests—02009
18 Mar 2026, 02:31Change of Director's Interest NoticeDirector Interests—02009
7 Mar 2026, 02:21Cleansing NoticeSecurities Administration—06018
7 Mar 2026, 02:14Application for quotation of securities - BDXOther—06020
21 Feb 2026, 06:26Change of Director's Interest NoticeDirector Interests—02009
18 Feb 2026, 22:33BCAL Half Year Results Presentation December 2025Financial Results—03004, 03026
18 Feb 2026, 06:47Half Yearly Report and AccountsFinancial ResultsMS03004, 03009, 03010, 03015, 03019
13 Feb 2026, 21:13BCAL Webinar Review Half Year Results 18 February 11am AEDTPresentations—14014
5 Feb 2026, 19:24Shareholder UpdateCompany UpdateMS11001
3 Feb 2026, 19:45Initial Director's Interest NoticeDirector Interests—02008
27 Jan 2026, 19:51Mr Mark McConnell Appointed to the BoardCompany Administration—12001
21 Jan 2026, 19:53Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19002, 19007
20 Jan 2026, 02:23Change in substantial holdingSubstantial Holders—02002
15 Dec 2025, 19:19Application for quotation of securities - BDXOther—06020
9 Dec 2025, 19:23Pancreatic and Ovarian Cancer Early Detection Blood TestingCompany Update—11001
3 Dec 2025, 19:28Ethics Approval to Establish BREASTEST RegistryCompany Update—11001
29 Nov 2025, 00:17Results of MeetingMeetings & Governance—08003
28 Nov 2025, 21:47BCAL AGM PresentationPresentations—03026, 15002
26 Nov 2025, 19:29BCAL Receives R&D Tax Offset $2.5 millionPeriodic Reports—03014, 12008
19 Nov 2025, 19:32BCAL Early Cancer Detection Tests UpdateCompany UpdateMS11001
7 Nov 2025, 19:28Change of Director's Interest NoticeDirector Interests—02009
31 Oct 2025, 20:08Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19001, 19006
29 Oct 2025, 03:38Letter to Shareholders Re Annual General MeetingMeetings & Governance—08006, 16002
29 Oct 2025, 03:38Notice of Annual General Meeting/Proxy FormMeetings & Governance—08001, 08004
28 Oct 2025, 05:35Application for quotation of securities - BDXOther—06020
21 Oct 2025, 20:40Proposed issue of securities - BDXSecurities Administration—06013
20 Oct 2025, 20:50BCAL Establishes $10m Convertible Note Facility RevisedSecurities AdministrationMS06009
20 Oct 2025, 19:28BCAL Establishes $10 million Convertible Note FacilitySecurities AdministrationMS06009
24 Sept 2025, 19:27Investor UpdatePresentations—03026
23 Sept 2025, 20:48Investor Webinar 24 September 2025 11am AESTPresentations—14014
18 Sept 2025, 20:00BCAL and ClearNote Partner on Early Cancer Detection TestsCompany UpdateMS11001
8 Sept 2025, 18:24Change of Director's Interest NoticeDirector Interests—02009
8 Sept 2025, 18:24Final Directors Interest Notice X 2Director Interests—02010
1–50 of 54
1 / 2